Guizhou Bailing Group Pharmaceutical: Special note by the board of directors on the 2023 audit report with reservations issued by accounting firms with highlighted sections

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.